The integrated AIM 5 syringe line with selectable AI is designed for the inspection of the flange, the stopper, and the cylinder
Process and packaging technology provider Syntegon Technology has expanded its AIM 5 inspection range with the introduction of a new fully integrated syringe inspection line with artificial intelligence (AI) technology.
The integrated AIM 5 syringe line with selectable AI by is suitable for the inspection of the flange, the stopper, and the cylinder.
The AI vision system has the potential to enhance detection rates and minimise the number of false rejects, specifically in difficult products such as highly viscous parenteral solutions with air bubbles.
Designed for gentle handling, the system consists of de-nester to remove the syringes from the nest and place them accurately in a single infeed lane. The re-nester gently puts them back into the nest after inspection.
According to the company, the single human machine interface (HMI) can be used to operate the new fully integrated syringe inspection line.
With an output of around 18,000 inspected syringes per hour, the system features modular design that includes a pre-inspection, a pre-spin and a main inspection module.
The static division (SD) technology is used to conduct the visual particle inspection. In addition, the high-voltage leak detection (HVLD) module can be incorporated for CCI testing, the company said.
Syntegon stated that it deployed the first fully validated AI-equipped visual inspection system on the market at the staring of this year.
Syntegon vision inspection development and applications leader Dr José Zanardi said: “When drugs are administered intravenously, any contamination or particle in the product is unacceptable.
“Our innovative and fully integrated inspection line handles syringes with utmost care and uses AI to further increase inspection accuracy.”
Last month, the company introduced a new capsule filling machine called GKF 60, which provides high flexibility and low space requirements for laboratories and research-based pharmaceutical companies.